Rivkin Center for Ovarian Cancer Research

What Rivkin Center for Ovarian Cancer Research does

The Rivkin Center for Ovarian Cancer Research is a Seattle-based non-profit organization founded in 1996 that operates in the ovarian cancer research and education domain. With a headcount of 16 employees, it is a small, focused institution whose primary functional role is to fund, coordinate, and communicate ovarian cancer research, alongside education and survivor-support programming that typically accompanies disease-specific research foundations.

The organization's core activities center on ovarian cancer — a narrow therapeutic area — and it operates from a single location in Seattle, Washington. The available source material does not disclose proprietary technology, products, digital platforms, or a defined research portfolio; the underlying content loaded from the company's primary web source was a verification/loading page that did not surface substantive product, technical, or programmatic detail. Consequently, the operating model is best characterized as a community- and donor-funded research support organization rather than a technology or therapeutics developer.

The business model follows the standard non-profit revenue mechanics for a small disease-focused foundation: philanthropic donations, community fundraising events, and likely institutional grants and partnerships. No pricing model, customer segments, or revenue figures are disclosed in the input, and there are no signs of commercial product revenue. The center's economic footprint is constrained by its small staff and single-site presence, making it dependent on continued donor engagement and partner relationships for operational sustainability.

Name

Rivkin Center for Ovarian Cancer Research

Legal name

Rivkin Center for Ovarian Cancer Research

Website

https://rivkin.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Rivkin Center for Ovarian Cancer Research is a Seattle-based non-profit founded in 1996 that funds ovarian cancer research and provides related education and community programs, supported by a 16-person staff and philanthropic contributions.

Ownership category

akta.pro rank

Product category

Non-profit Cancer Research

NAICS

Voluntary Health Organizations (813212)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industries

Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK), Gynecologic Oncology (HLAKAFAF)

Keywords

• Ovarian cancer research
• Cancer research grants
• Cancer awareness education
• Cancer survivor support
• Nonprofit research funding

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Core offering

The Rivkin Center for Ovarian Cancer Research is a non-profit organization that funds ovarian cancer research through grants, raises disease awareness via educational programs, and provides community support for patients, survivors, and families. It also hosts community fundraising events (such as the SummeRun) to sustain its research and education mission.

Product overview

No product information available. The source content displayed only a loading/verification page ("One moment, please...") with no substantive content about products or services.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Emerging players

• Bright Pink: A nonprofit focused on breast and ovarian cancer risk assessment and early detection for young women. It is an emerging player in women's cancer nonprofit work with overlapping awareness and education programming.
• Stand Up To Cancer: A nonprofit that funds collaborative, translational cancer research through high-profile grants and televised fundraising campaigns. It competes for donor attention in cancer research philanthropy with a more media-forward model.

Broad incumbents

• American Cancer Society: The largest U.S. cancer-focused nonprofit, funding multi-disease research including ovarian cancer. As a broad incumbent, it competes with the Rivkin Center for donor dollars and research talent but operates across many cancer types.
• Susan G. Komen: A large women's-cancer nonprofit historically focused on breast cancer but increasingly active in broader gynecologic cancer research. It is a broad incumbent in women's cancer philanthropy with overlapping donor audiences.

Direct peers

• Prevent Cancer Foundation: A nonprofit that funds cancer prevention and early-detection research across multiple cancer types, including ovarian. It is comparable to Rivkin as a peer research-focused nonprofit operating in oncology philanthropy.
• National Foundation for Cancer Research: A nonprofit that supports cancer research through grants and collaborative programs across multiple cancer types. It is comparable to Rivkin in the nonprofit research-funding space and competes for similar institutional and individual donors.
• Ovarian Cancer Research Alliance: The largest U.S. nonprofit focused specifically on ovarian cancer research, advocacy, and survivor support. It is the most direct comparable to the Rivkin Center in mission, donor audience, and grantmaking activity.
• V Foundation for Cancer Research: A nonprofit that funds cancer research broadly via research grants, including gynecologic cancers. It is comparable to Rivkin as a peer nonprofit cancer research funder with a grants-based programmatic model.
• National Ovarian Cancer Coalition: A national nonprofit dedicated to ovarian cancer awareness, education, and research funding. It targets a similar donor and patient community and is a direct peer in disease-specific women's cancer philanthropy.

Regional players

• Fred Hutchinson Cancer Center: A major Seattle-based cancer research and treatment institution. As a geographically proximate research powerhouse, it is both a potential partner and a regional anchor that shapes the Rivkin Center's operating environment.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/rivkin-center

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rivkin Center for Ovarian Cancer Research